Since sequencing of exons and flanking intronic sequences of the APRT gene permits identifying about 90% of mutations27, the mutation analysis of APRT gene can be used as first-line test for the diagnosis of this rare metabolic disorder when other techniques are not considered or unavailable. This evidence concerns the gene APRT and metabolic disease.